Replies to post #230728 on Biotech Values

[DewDiligence]

PFE’s COVID-19 program pursuing several avenues:

https://finance.yahoo.com/news/pfizer-advances-battle-against-covid-115000555.html

https://www.wsj.com/articles/pfizer-identifies-lead-coronavirus-drug-candidate-11586427303

[DewDiligence]

PFE +5% on initial COVID-19-vaccine data:

https://endpts.com/pfizer-shares-surge-on-positive-impact-of-their-mrna-covid-19-vaccine-partnered-with-biontech-in-an-early-stage-study/

Curiously, PFE’s partner on this program, BNTX, is up only 3% as I’m typing.

[DewDiligence]

PFE/BNTX slides re—(1st of 4)—COVID-19 vaccine (released yesterday morning):

https://investors.biontech.de/static-files/c4feb567-e564-40e5-a9cf-538892af1c04

Accompanying PR:
https://finance.yahoo.com/news/pfizer-biontech-announce-early-positive-130128826.html